Cytoreductive Surgery with HIPEC

The peritoneum is the smooth lining that wraps the inside of the abdomen and covers the organs within it. Some cancers, including those of the appendix, the large bowel, the ovary and the stomach, as well as a cancer that starts in the peritoneum itself called peritoneal mesothelioma, can spread as scattered deposits across this lining rather than to distant organs. When the disease stays on the peritoneal surface in this way, removing it surgically and treating the area directly can be far more effective than drugs given through a vein alone. Cytoreductive surgery is the painstaking removal of all visible tumour, which may involve stripping affected areas of peritoneum and removing parts of organs that the cancer has reached. HIPEC then bathes the cleared cavity in a warmed chemotherapy solution, usually heated to around 41 to 43 degrees Celsius and circulated for roughly 30 to 90 minutes. The heat makes the cancer cells more vulnerable and helps the drug penetrate, so the two steps together aim to leave behind as little disease as possible.

This treatment is considered when cancer has spread to the peritoneal lining but has not spread widely to distant organs such as the lungs, bones or brain, and when imaging and assessment suggest that all visible disease can realistically be removed. The conditions most often treated this way include pseudomyxoma peritonei (a slow-growing condition usually arising from the appendix), peritoneal mesothelioma, and peritoneal spread from cancers of the appendix, the colon and rectum, the ovary and, in selected cases, the stomach. The decision is never made on a scan alone. A specialised team weighs the type and extent of the cancer, the patient's general health and fitness for a long operation, and the results of previous treatments, and the final extent of spread is sometimes confirmed with a small keyhole look inside the abdomen before committing to the full procedure. Because the operation is most successful when the disease is limited, earlier referral generally widens the options.

The operation is carried out under general anaesthesia and usually begins with a long incision down the middle of the abdomen so the whole cavity can be examined and treated. The surgeon then performs the cytoreduction, methodically removing every visible tumour deposit; this can include peeling diseased peritoneum from the abdominal wall and diaphragm and removing involved sections of bowel, omentum or other organs, with the aim of leaving no tumour larger than a tiny nodule. Once the cavity is clear, the HIPEC phase begins. Catheters are placed into the abdomen and a chemotherapy solution, warmed to a precise temperature, is circulated continuously through the cavity for a set period while the temperature and flow are carefully monitored, so the drug reaches all surfaces evenly. The solution is then drained, any necessary reconstruction such as rejoining the bowel is completed, and the abdomen is closed. The whole procedure commonly takes between six and twelve hours, and the length depends mainly on how much disease has to be removed.

A suitable candidate has peritoneal-surface cancer that appears removable, is otherwise well enough to withstand a major operation and a longer recovery, and has had the disease reviewed by a team experienced in this field. Preparation is thorough. It typically includes detailed cross-sectional imaging of the chest, abdomen and pelvis, blood tests including tumour markers, an assessment of heart and lung fitness, and a careful review of nutrition, because being in good nutritional condition helps recovery. Existing treatments and medicines, particularly blood thinners, are reviewed and adjusted on medical advice, and stopping smoking well in advance is strongly encouraged. For international patients, much of this assessment can begin from home: recent scans, pathology reports and a medical summary are reviewed remotely so the team can give an informed opinion on suitability before travel, with the final imaging, blood work and any keyhole assessment completed on arrival before the operation is scheduled.

Recovery from cytoreductive surgery with HIPEC is more involved than from many other operations, because it combines major abdominal surgery with chemotherapy delivered into the body. Most patients spend the first day or two in an intensive care or high-dependency unit for close monitoring, then move to a normal ward as they stabilise. The bowel needs time to start working again, so eating is reintroduced gradually, and tubes and drains are removed step by step as healing progresses. A typical hospital stay is around one to three weeks. Strength returns over the following weeks, and most people are back to their normal routine within roughly six to twelve weeks, though this varies with the extent of the surgery and individual health. Planning a trip abroad, it is sensible to allow for a stay of about three to four weeks in total, so that the operation, the hospital recovery and an outpatient check can all be completed before flying. Air travel is generally advised only once the surgical team confirms that healing is on track. Afterwards, follow-up continues remotely, and international patient teams commonly provide interpreters and coordinators so that language is never a barrier.

In experienced hands and a properly equipped hospital, cytoreductive surgery with HIPEC is an established treatment, but it is a large operation and carries more risk than routine surgery, which is exactly why it should be done only in specialised centres. Possible complications include bleeding, infection, leakage where the bowel is rejoined, temporary slowing of the bowel, blood clots, and effects from the chemotherapy such as a temporary drop in blood counts; the team takes detailed precautions to prevent and manage each of these, and the longer monitoring period is part of keeping patients safe. The potential benefit is significant: for suitable patients, removing all visible disease and treating the area directly can provide long-term control of cancers that drugs alone struggle to hold, and for some it offers the best chance of a durable result. Success depends heavily on careful patient selection, the completeness of the surgery and the experience of the team, which is why choosing a centre that performs this procedure regularly matters so much.